Growing Foreign Presence In China's Pharma Industry

21 September 1997

by Jiang Song of Beijing Cons Bio-Tech

The growth of China's pharmaceutical industry has been phenomenal in the last decade. In the 1990s, the total sales of this industry have been growing at a pace of 30% to reach $10.6 billion in 1996.

The pharmaceutical industry was one of the first sectors to open up to foreign investors in China. Since 1980, when the first Sino-foreign pharmaceutical joint venture was set up, direct foreign investments have been pouring into the pharmaceutical industry.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight